ANI PHARMACEUTICALS INC Quarterly Costs and Expenses in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Ani Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q2 2024.
  • Ani Pharmaceuticals Inc Costs and Expenses for the quarter ending June 30, 2024 was $133M, a 27.6% increase year-over-year.
  • Ani Pharmaceuticals Inc Costs and Expenses for the twelve months ending June 30, 2024 was $489M, a 27.9% increase year-over-year.
  • Ani Pharmaceuticals Inc annual Costs and Expenses for 2023 was $440M, a 25.1% increase from 2022.
  • Ani Pharmaceuticals Inc annual Costs and Expenses for 2022 was $352M, a 37.4% increase from 2021.
  • Ani Pharmaceuticals Inc annual Costs and Expenses for 2021 was $256M, a 14% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $489M $133M +$28.7M +27.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $460M $117M +$20.2M +20.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $440M $125M +$32.5M +35.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $407M $114M +$25.1M +28.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $382M $104M +$17.4M +20% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $365M $96.9M +$13.2M +15.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $352M $92.4M +$7.76M +9.17% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $344M $88.8M +$33.2M +59.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $311M $86.8M +$22.6M +35.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $288M $83.7M +$32.2M +62.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $256M $84.7M +$27.7M +48.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $228M $55.6M +$5.45M +10.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $223M $64.2M +$4.4M +7.36% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $218M $51.5M -$6.14M -10.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $224M $56.9M +$4.28M +8.14% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 $220M $50.2M +$6.17M +14% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $214M $59.8M +$14.7M +32.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $199M $57.6M +$9.13M +18.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $190M $52.6M +$6.96M +15.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $183M $44M +$3.42M +8.43% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $180M $45.1M +$5.06M +12.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 $175M $48.5M +$8.54M +21.4% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 $166M $45.7M +$5.77M +14.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $160M $40.6M +$1.76M +4.52% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $159M $40M +$2.24M +5.92% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $156M $39.9M +$7.94M +24.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 $149M $39.9M +$3M +8.13% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $146M $38.8M +$8.23M +26.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 $137M $37.8M +$11.6M +44.5% Mar 31, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $126M $32M +$17.1M +115% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 $109M $36.9M +$25.1M +214% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 $83.4M $30.6M +$19.1M +166% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 $64.3M $26.1M +$15M +135% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 $49.3M $14.9M +$5.66M +61.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 $43.6M $11.8M +$1.5M +14.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 $42.1M $11.5M +$2.33M +25.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 $39.8M $11.1M +$2M +21.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 $37.8M $9.23M +$1.83M +24.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 $36M $10.3M +$3.19M +45.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-23
Q3 2014 $32.8M $9.19M +$2.16M +30.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-23
Q2 2014 $30.6M $9.11M -$820K -8.26% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-23
Q1 2014 $31.4M $7.4M +$2.25M +43.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-23
Q4 2013 $29.2M $7.07M +$3.55M +101% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 $25.6M $7.03M +$1.78M +34% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $23.9M $9.93M +$5.33M +116% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $18.5M $5.16M -$1.89M -26.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $20.4M $3.52M -$4.98M -58.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 $25.4M $5.24M -$7.97M -60.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $33.4M $4.6M -$8.55M -65% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $41.9M $7.05M -$9.45M -57.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $51.4M $8.51M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 $13.2M +$1.92M +17% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $13.1M +$2.91M +28.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 $16.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q3 2010 $11.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $10.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.